Suppr超能文献

标准化程序可预防完全植入式静脉输液港的围手术期和早期并发症——1000 多例 TIVAP 植入术的并发症分析。

Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.

机构信息

Department of General, Visceral and Transplant Surgery, Tuebingen University Hospital, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany.

出版信息

Langenbecks Arch Surg. 2022 Dec;407(8):3755-3762. doi: 10.1007/s00423-022-02656-9. Epub 2022 Sep 7.

Abstract

PURPOSE

Since their invention 40 years ago, totally implantable venous-access ports (TIVAPs) have become indispensable in cancer treatment. The aim of our study was to analyze complications under standardized operative and perioperative procedures and to identify risk factors for premature port catheter explantation.

METHODS

A total of 1008 consecutive TIVAP implantations were studied for success rate, perioperative, early, and late complications. Surgical, clinical, and demographic factors were analyzed as potential risk factors for emergency port catheter explantation.

RESULTS

Successful surgical TIVAP implantation was achieved in 1005/1008 (99.7%) cases. No intraoperative or perioperative complications occurred. A total of 32 early complications and 88 late complications were observed leading to explantation in 11/32 (34.4%) and 34/88 (38.6%) cases, respectively. The most common complications were infections in 4.7% followed by thrombosis in 3.6%. Parameters that correlated with unplanned TIVAP explantation were gender (port in situ: female 95% vs. male 91%, p = 0.01), underlying disease (breast cancer 97% vs. gastrointestinal 89%, p = 0.004), indication (chemotherapy 95% vs. combination of chemotherapy and parenteral nutrition 64%, p < 0.0001), and type of complication (infection 13.4% vs. TIVAP-related complication 54% and thrombosis 95%, p < 0.0001).

CONCLUSION

Standardized operative and perioperative TIVAP implantation procedures provide excellent results and low explantation rate.

摘要

目的

自 40 年前发明以来,完全植入式静脉接入端口(TIVAP)在癌症治疗中已不可或缺。本研究旨在分析标准化手术和围手术期操作下的并发症,并确定导致 TIVAP 导管过早拔除的危险因素。

方法

对 1008 例连续 TIVAP 植入术的成功率、围手术期、早期和晚期并发症进行研究。分析手术、临床和人口统计学因素是否为紧急 TIVAP 导管拔除的潜在危险因素。

结果

1005/1008(99.7%)例 TIVAP 手术植入成功。术中或围手术期均未发生并发症。共观察到 32 例早期并发症和 88 例晚期并发症,分别导致 11/32(34.4%)和 34/88(38.6%)例 TIVAP 导管拔除。最常见的并发症是感染(4.7%),其次是血栓形成(3.6%)。与计划外 TIVAP 拔除相关的参数有性别(TIVAP 原位:女性 95% vs. 男性 91%,p=0.01)、基础疾病(乳腺癌 97% vs. 胃肠道癌 89%,p=0.004)、适应证(化疗 95% vs. 化疗联合肠外营养 64%,p<0.0001)和并发症类型(感染 13.4% vs. TIVAP 相关并发症 54%和血栓形成 95%,p<0.0001)。

结论

标准化的 TIVAP 手术和围手术期操作可获得出色的效果,且 TIVAP 拔除率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/9722872/aa7904b9f140/423_2022_2656_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验